Urine free cortisolBiomarker1 paperLatestENDO 2025 Abstract·23 OctMON-209 Perimenopause as a Vulnerable Period for Obesogenic MedicationsCase reportInterventionsPaper
ENDO 2025 Abstract·23 OctMON-209 Perimenopause as a Vulnerable Period for Obesogenic MedicationsCase reportInterventionsPaper